Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2007 | 1 |
2009 | 1 |
2011 | 1 |
2016 | 1 |
2017 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
J Virol Methods. 2017 Mar;241:41-45. doi: 10.1016/j.jviromet.2016.12.008. Epub 2016 Dec 16.
J Virol Methods. 2017.
PMID: 27993614
Free PMC article.
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study.
Grinsztejn B, Hughes MD, Ritz J, Salata R, Mugyenyi P, Hogg E, Wieclaw L, Gross R, Godfrey C, Cardoso SW, Bukuru A, Makanga M, Faesen S, Mave V, Wangari Ndege B, Nerette Fontain S, Samaneka W, Secours R, van Schalkwyk M, Mngqibisa R, Mohapi L, Valencia J, Sugandhavesa P, Montalban E, Avihingsanon A, Santos BR, Kumarasamy N, Kanyama C, Schooley RT, Mellors JW, Wallis CL, Collier AC; A5288 Team.
Grinsztejn B, et al.
Lancet HIV. 2019 Sep;6(9):e588-e600. doi: 10.1016/S2352-3018(19)30146-8. Epub 2019 Jul 29.
Lancet HIV. 2019.
PMID: 31371262
Free PMC article.
Clinical Trial.
Item in Clipboard
Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitors.
Smith PF, Robbins GK, Shafer RW, Wu H, Yu S, Hirsch MS, Merigan TC, Park JG, Forrest A, Fischl MA, Morse GD; ACTG 384-5006 Team.
Smith PF, et al.
Antimicrob Agents Chemother. 2005 Aug;49(8):3558-61. doi: 10.1128/AAC.49.8.3558-3561.2005.
Antimicrob Agents Chemother. 2005.
PMID: 16048984
Free PMC article.
Clinical Trial.
Item in Clipboard
Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.
Schackman BR, Scott CA, Sax PE, Losina E, Wilkin TJ, McKinnon JE, Swindells S, Weinstein MC, Freedberg KA.
Schackman BR, et al.
Clin Infect Dis. 2007 Oct 15;45(8):1062-70. doi: 10.1086/521933. Epub 2007 Sep 4.
Clin Infect Dis. 2007.
PMID: 17879926
Free PMC article.
Item in Clipboard
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes.
Wilkin TJ, McKinnon JE, DiRienzo AG, Mollan K, Fletcher CV, Margolis DM, Bastow B, Thal G, Woodward W, Godfrey C, Wiegand A, Maldarelli F, Palmer S, Coffin JM, Mellors JW, Swindells S.
Wilkin TJ, et al.
J Infect Dis. 2009 Mar 15;199(6):866-71. doi: 10.1086/597119.
J Infect Dis. 2009.
PMID: 19191590
Free PMC article.
Clinical Trial.
Item in Clipboard
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participants.
Grady BJ, Torstenson ES, McLaren PJ, DE Bakker PI, Haas DW, Robbins GK, Gulick RM, Haubrich R, Ribaudo H, Ritchie MD.
Grady BJ, et al.
Pac Symp Biocomput. 2011:253-64. doi: 10.1142/9789814335058_0027.
Pac Symp Biocomput. 2011.
PMID: 21121053
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite